Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>Vance G. Fowler, Sara E. Cosgrove, Christopher H. Cabell et al.|New England Journal of Medicine|2006Cited by 1.5k
Initial Low‐Dose Gentamicin for<i>Staphylococcus aureus</i>Bacteremia and Endocarditis Is NephrotoxicSara E. Cosgrove, Helen W. Boucher, Gloria Vigliani et al.|Clinical Infectious Diseases|2009Cited by 305
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic responseScott Berry, Christopher W. Woods, Elizabeth Petzold et al.|Clinical Trials|2016Cited by 68
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupSarah B. Doernberg, Thomas L Holland, Thomas P. Lodise et al.|Clinical Infectious Diseases|2016Cited by 62
A randomized, blinded, multicenter trial of a gentamicin vancomycin gel (DFA-02) in patients undergoing abdominal surgeryElliott Bennett‐Guerrero, Kent Allenby, Scott Berry et al.|The American Journal of Surgery|2016Cited by 18